Purpose
To develop a prophylactic HIV vaccine using the HCMV vector platform that can address the prevention needs in low- and middle-income countries and therefore reach those individuals most in need of HIV prevention
Grantee
Division
Global Health
Date
MARCH 2023
Region served
GLOBAL
Committed amount
$10,000,000
Grant topic
HIV
Duration (months)
51
Grantee location
San Francisco, California, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.